By NOF, WASHINGTON, DC; Thursday, October 29, 2009

National Osteoporosis Foundation and International Society for Clinical Densitometry Team Up for 2010 Annual Meeting

(Washington, DC) — The International Society for Clinical Densitometry (ISCD) and National Osteoporosis Foundation (NOF) have combined efforts to assist the clinician and technologist in providing the most relevant, up-to-date information for clinical practice atCLINICAL OSTEOPOROSIS 2010: An ISCD-NOF Symposium.

As the foremost bone health organizations in professional education and consumer information, both bring their extensive expertise together for an in-depth meeting that convenes top researchers, clinicians and technologists in an important conference about cutting-edge advances in the prevention, diagnosis and treatment of osteoporosis.

"We're looking forward to working with NOF in executing this comprehensive symposium for the benefit of our respective members," said Peter Brown, executive director, ISCD. This premier event exposes attendees to the latest, evidence-based information on osteoporosis and bone health in one must-attend professional development opportunity.

"This is an exciting venture for both organizations to work together and highlight the best information available for optimal management of osteoporosis and overall bone health," said Susan Sarfati, interim executive director, NOF.

CLINICAL OSTEOPOROSIS 2010 will offer in-depth and interactive educational sessions addressing epidemiology, pathophysiology, genetics; primary and secondary osteoporosis; diagnosis and risk assessment; clinical considerations, therapeutics; sociobehavioral medicine, nutrition, education; technology; and emerging science.

The symposium will be held at the Grand Hyatt in San Antonio, Texas from March 10 – 13, 2010. For details on this premier meeting and to register, please visit www.clinicalosteoporosis.org.

Celebrating 25 years of Standing Tall for You®, the National Osteoporosis Foundation is the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health. Its mission is to prevent osteoporosis, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis and related fractures, and to find a cure through programs of awareness, education, advocacy and research. For more information on osteoporosis and bone health, contact NOF online at www.NOF.org or by phone 1-800-223-9994.

The International Society for Clinical Densitometry is dedicated to promoting education and broader understanding of the clinical applications of skeletal health assessment; to assuring proficiency and quality in the assessment of skeletal health through certification; to promoting appropriate patient access to skeletal health assessment technologies; and to supporting clinical and scientific advances in the diagnosis and treatment of osteoporosis: For additional information, visit the ISCD Web site at www.ISCD.org or call 860.586.7563.

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.